Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features
Public ClinicalTrials.gov record NCT05131139. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Enhance Study: A Prospective, Multicenter Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features
Study identification
- NCT ID
- NCT05131139
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Senseonics, Inc.
- Industry
- Enrollment
- 350 participants
Conditions and interventions
Interventions
- Continuous Glucose Monitoring System Device
Device
Eligibility (public fields only)
- Age range
- 14 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 19, 2021
- Primary completion
- Mar 29, 2025
- Completion
- Sep 29, 2025
- Last update posted
- Apr 25, 2023
2021 – 2025
United States locations
- U.S. sites
- 4
- U.S. states
- 4
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| AMCR Institute Inc. | Escondido | California | 92025 | Recruiting |
| Rocky Mountain Diabetes Center, LLC. (RMDC) | Idaho Falls | Idaho | 83404 | Recruiting |
| Clinical Trials of Texas, LLC. (CTT) | San Antonio | Texas | 78229 | Recruiting |
| Rainier Clinical Research Center | Renton | Washington | 98057 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05131139, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 25, 2023 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05131139 live on ClinicalTrials.gov.